1 October 2022

37th Process Development Symposium

Organised by:

SCI's Fine Chemicals Group

Cambridge, UK

Registration Closed

This event is no longer available for registration.

Synopsis

This page is a test page for a website update. Please do NOT register for this event. Thank you.

Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full-scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering. The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.

Attendees

The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state-of-the-art process development. As an established and well attended meeting, the process development symposium offers an excellent opportunity for networking between like-minded process scientists of all levels of experience and from all areas of the chemical industry.

Programme

Wednesday 25 March
11.00: Registration and refreshments
12.15: Lunch and exhibition; CHAIRPERSON: Stella James, Bionow, UK
13.25: Opening remarks
13.30: Engineering Approaches in Pharmaceutical Chemical Process Development
Dr Suju Matthew, Pfizer, UK
14.10: Davis oxaziridines: development and applicationse
Laurent Petit, Minakem, Belgium
14.50: Experimental design and its place in process development
Laura Forfar, Catalysis Consulting Ltd, UK
15.30: Refreshment break and exhibition; CHAIRPERSON: David Lathbury, Astute Chemical Development Consulting Ltd, UK
16.10: Probing reagent / catalyst (dis)function
Guy Lloyd Jones, University of Edinburgh, UK
16.50: Process development of a robust manufacturing route for bridion
Sue Zultanski, MSD, USA
17.30: Closing remarks
17.45: Wine reception sponsored by Chiralquest
19.00: Dinner for residents; Thursday 26 March; CHAIRPERSON: Max Espensen, Pharmaron, UK
09.00: Site-Specific and Enantioselective sp3 C-H Functionalization
Prof Guosheng Liu, SIOC, China (remote presentation)
09.40: Application of transition-metal catalysis, biocatalysis and flow chemistry as state-of-the-art technologies in the synthesis of LCZ696
Florian Kleinbeck, Novartis, Switzerland
10.20: Refreshment break and exhibition; CHAIRPERSON: Hazmi Tajuddin, Syngenta, UK
10.50: Automation and autonomy to enable process chemistry
Jason Hein, University of British Columbia, Canada
11.30: Process development in the synthesis of CF corrector VX-661
Christian Harrison, Vertex, USA
12.10: Lunch and exhibition; CHAIRPERSON: Andy Wells, Charnwood Technical Consulting, UK
13.10: An enantioselective total synthesis of (+)-duocarmycin SA
Michael Schmidt, Bristol-Myers Squibb, USA
13.50: Racing to the finish: the benefit of 3D printed flow reactors in scale-up
Lana Borukhova, Innosyn, The Netherlands
14.30: The application of C-H functionalisation in the development of a concise and convergent route to nemiralisib
Katherine Wheelhouse, GlaxoSmithKline, UK
15.10: Refreshment break and exhibition; CHAIRPERSON: David Lathbury, Astute Chemical Development Consulting Ltd, UK
15.40: Right particle journey: crystallisation process development from labs to scale to support drug product processing
Rachel Sullivan, AstraZeneca, UK
16.20: Process chemistry award winner 2019
Prof Ross Denton, University of Nottingham, UK
17.20: Closing remarks
17.30: Wine reception sponsored by Johnson Matthey
19.00: Conference dinner; Friday 27 March; CHAIRPERSON: David Pascoe, GlaxoSmithKline, UK
09.00: New perspectives: approaches for the application of metal scavengers to impurity control in pharma
Sunil Rana, Biotage GB, UK
09.40: Processing of high-aspect ratio particles
Frans L. Muller, University of Leeds
10.20: Refreshment break and exhibition; CHAIRPERSON: Rob Walton, Pfizer, UK
10.50: Particle design and modelling technologies for API manufacturing
Claire Wombwell, Johnson Matthey, UK
11:30: Solvent selection methods and tool
Julia Baumeister, Syngenta, UK
12:10: Closing remarks

Venue and Contact

Churchill College

Storey’s Way
Cambridge

CB3 0DS
UK

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees

Early bird fees before Friday 31 January 2020

£380		SCI Member
£260		SCI Subsidised Member
£425		Non-Member

Standard fees after Friday 31 January 2020

£495		SCI Member
£290		SCI Subsidised Member
£550		Non-Member

SCI Platinum Corporate Members receive 25% off the above rates.

Accommodation Fees

£162		Standard Accommodation
£203		Ensuite Accommodation

Accommodation can be booked for delegates at the college in single study ensuite or standard bedrooms. Bedrooms will be allocated on a first come, first served basis.The accommodation package is for 2 nights - Wednesday 25 and Thursday 26 March and includes full English or Continental breakfast.

Rooms must be vacated by 10.00am on the day of departure.

You will have the opportunity to book this as part of the online booking process when you register for the event.

Please note: Bedrooms at the college will be available from 14.00 on the day of arrival. Those not wishing to stay in college accommodation can book accommodation directly through www.visitcambridge.org.

Student Bursaries

A limited number of student bursaries are available to registered participants, as a contribution to the cost of registration fees, travel or accommodation. To receive an application form and for more information, please email conferences@soci.org

Become an SCI Member and save on this and future events

See Membership Options

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd event - The CPD Standards Office

Additional Info

Organising committee

Louis Diorazio, SCI/AstraZeneca
Max Espensen, Pharmaron
Stella James, SCI/Bionow
Dave Lathbury, SCI/Astute Chemical Development Ltd
David Pascoe, SCI/GlaxoSmithKline
Hazmi Tajuddin, SCI/Syngenta
Robert Walton, SCI/Pfizer
Andy Wells, Charnwood Technical Consulting Ltd

Exhibition

An exhibition will run alongside the conference during refreshment breaks, for companies and related organisations who may wish to exhibit. For further information and prices please email jacqui.maguire@soci.org